Immunovant Employee Directory
Biotechnology ResearchNew York, United States201-500 Employees
Immunovant is a clinical-stage biotechnology company focused on immunology, developing targeted therapies for autoimmune diseases. Its work centers on anti-FcRn technology designed to address the diverse needs of patients with autoimmune conditions. Based in New York, it operates within the biotechnology research sector and maintains a mid-sized team. Recent Phase 2 data for IMVT-1402 in difficult-to-treat rheumatoid arthritis report ACR20/50/70 response rates of 72.7%, 54.5%, and 35.8%. The results suggest potential for IMVT-1402 across autoimmune diseases and support the company's development efforts in this area. More information about Immunovant is available at immunovant.com.